• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BD Recalls Intraosseous Products Over Multiple Issues

    Rapid Medical Expands U.S. Portfolio

    MMS Holdings Partners With Lindsay Goldberg

    ENDRA Life Sciences Issued 28th Patent

    Levita Magnetics Closes $26M Series C
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Concise Engineering

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Concise Engineering

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Funding Tips to Help Medtech Startups Cross the ‘Valley of Death’

    ...

    Funding Tips to Help Medtech Startups Cross the ‘Valley of Death’
    Related CONTENT
    • The 2019 Top 30 Global Medical Device Companies
    • 2. Johnson & Johnson
    • Verb Surgical Appoints New CEO
    • Hologic Partners with MagView to Develop Unifi EQUIP Solution
    • Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls
    David J. Dykeman, Co-chair, Global Life Sciences & Medical Technology Group, Greenberg Traurig LLP 07.30.19
    Bringing innovative medical technology to market today is as complex and competitive as it’s ever been for entrepreneurs and startups. One of the major hurdles for any early-stage medtech company is funding product development, and the venture capital sector has grown increasingly cautious.

    According to a MoneyTree report from PricewaterhouseCoopers and CB Insights, venture capital (VC) firms invested more than $2.9 billion in medical device companies in 2018, a slight increase from the $2.8 billion raised in 2017. Despite the modest uptick, the bar for new investments has been raised. Many VCs are waiting to invest until a device achieves sufficient safety and efficacy evidence, or until regulatory approval and reimbursement have been secured. In fact, over the last two years, 78 percent of medtech VC investment has gone to later stage deals (Series B+), with many companies raising commercialization rounds after FDA approval.1 In 2018, ophthalmology and neurology devices each had four VC deals valued over $150 million. The neurology deals were Series D or later, and six of the eight deals were commercial stage.1

    Faced with this financing challenge, early-stage medtech companies need to get creative and cast their nets widely for new sources of funding. Non-VC sources of financing are gaining popularity and providing medtech entrepreneurs with more choices than previously available.

    Seed Investments Can Help Launch a Startup
    Seed investment from angel investors, incubators, and accelerators can help startups move from an idea to proof of concept, and in the process, begin to de-risk the technology. Seed investment can reduce the amount future investors might need to invest to move new products through FDA approval and commercialization. Seed stage investment often takes the form of convertible notes or interest-bearing loans.

    Seek Non-Dilutive Funding
    Non-dilutive funding includes grants, awards, prizes, or contracts that do not require giving up any equity in the company. Sources of non-dilutive funding include the government, nonprofit entities, or charitable foundations.

    Government Grants: Various federal government agencies award grants and/or contracts to support medtech research and development, including the National Institutes of Health, National Science Foundation, Department of Defense, and Department of Energy. Some grants are awarded for groundbreaking science, while many federally funded research grants are directed toward specific diseases, organs, or stages of life. State agencies often give grants to companies located in economic development zones or that move to the state. One challenge with government grants is that startups need capital quickly, while government grant cycles move slowly, often taking six to 12 months.2

    America’s Seed Fund: The Small Business Innovation Research Program (SBIR) and the Small Business Technology Transfer Program (STTR), known as “America’s Seed Fund,” are the world’s largest source of non-dilutive, early-stage seed capital. Nearly 5,000 small businesses receive more than $2.5 billion in U.S. federal government grants and contracts to help them conduct the R&D needed to develop and bring high-tech products to market through the SBIR. Sponsored by various government agencies, SBIR grants can help bridge the period between the end of federally funded research and early-stage investment from angel or seed investors. SBIR eligibility requirements are straightforward—the business must be for-profit, have less than 500 employees, be independently owned, located principally in the U.S., and the principal researcher must be a company employee.

    Disease Foundations: Nonprofit disease foundations harness the collective power of the public, private, and academic sectors, fostering collaborations and serving as incubators. Disease foundations can move rapidly and have the flexibility to fund high-risk pilot studies outside the industry roadmap. Disease foundations can inspire follow-on funding from the government, incentivize larger companies to partner sooner, and engage experts with extensive experience in the regulatory process to create a well-defined strategy toward FDA approval. Disease foundations can provide philanthropic support for additional clinical trials and data collection to ensure that FDA-approved treatment options are covered by insurance companies and become broadly available to patients. The investment is also non-dilutive, since foundations typically do not take equity in the startup.

    Increased Corporate VC Interest
    The last decade has seen a dramatic rise in large medtech and life science companies creating venture funds to invest in promising early-stage medical technologies that align with industry giants. These company-based investment funds have stepped in to fill the funding gap and help early-stage medtech companies cross the valley of death. In the last few years, large medical companies have been competing in the race to acquire private medical device companies in the neurological, surgical, orthopedic, and cardiovascular spaces.

    Some recent examples of strategic investments by major players in early-stage companies include:
    • Third Pole Therapeutics, a company developing and delivering cardio-pulmonary therapies, announced a collaboration in March (2019) with Actelion Pharmaceuticals Ltd., a Janssen pharmaceutical company of Johnson & Johnson. The collaboration combines the resources and expertise of one of the largest and most respected healthcare companies to Third Pole’s platform technology, capable of expanding access to potentially lifesaving inhaled nitric oxide (iNO) therapy worldwide.3
    • In May 2019, Techsomed, an Israeli developer of ultrasound-based monitoring systems for thermal ablation procedures, raised $2.6 million—led by Johnson & Johnson Innovation—for obtaining regulatory approval of BioTrace, Techsomed’s real-time predictive imaging system for thermal ablation.4
    • In August 2018, Boston Scientific Corp. acquired Veniti Inc., which developed the Vici Venous Stent System for treating venous obstructive disease. In 2016, Boston Scientific invested in Veniti for 25 percent ownership. The transaction price for the remaining ownership stake included $108 million up-front cash, and up to $52 million in payments contingent upon FDA approval.5
    • In March 2018, Pear Therapeutics inked a deal with Novartis to develop digital therapeutics for multiple sclerosis and schizophrenia.6 In January this year, Novartis participated in a $64 million Series C financing of Pear, led by investment firm Temasek.7

    In addition to traditional sectors such as cardiovascular and orthopedics, medtech investments are being driven by new technologies in high demand, such as mobile health, big data, robotics, and artificial intelligence. As mobile health continues to become more ubiquitous, digital and mobile health solutions are becoming increasingly important to traditional medical device companies as investment, partnership, and acquisition targets.

    Patents Attract Funding
    A strategic patent portfolio protects a company’s core technology, which in turn helps secure funding and establishes a competitive market advantage. A recent study found a startup has about a 2.5 times greater chance of achieving success within 10 years of VC investment if it holds patents before the investment.

    Patents are extremely important for medtech companies in all stages. For early-stage companies, patents are often the only way for investors to place a value on a company’s technology before regulatory approval. In this way, patents make up a significantly greater portion of enterprise value for early-stage medtech firms than for other startups. As a company grows, patents become the currency to secure financing through venture capital or private equity investment. Patents can also lead to collaborations, joint ventures, and licenses with strategic partners.

    For early-stage medtech companies, the key is to develop a strategic patent portfolio that has comprehensive patent coverage around its innovations. The core technology must have adequate patent protection to provide flexibility and room to operate in a desirable market. Companies should file one or a series of patent applications providing the broadest possible patent protection to cover the company’s core technology. To obtain broad patent protection, a medtech company should consider both current and future business objectives and contemplate ways that competitors may attempt to design around its patents.

    Tips to Attract Investment
    Emerging medtech firms that have developed value-driven patent portfolios can maximize opportunities for investment and partnering deals. Besides building a strategic patent portfolio, early-stage medtech companies should consider the following tips to become attractive targets for investment.

    Focus on innovation:  Early-stage companies can sometimes act as outsourced R&D laboratories for larger players. Investors desire access to next-generation technology that disrupts medtech markets, even if regulatory approval is years away. 

    Think long-term: Early-stage firms should plan for investment and partnering deals years in advance. Larger medical device companies are concerned about limiting risk and often monitor a product for years to get comfortable with the technology and management team before investing. 

    Start de-risking on day one:  A medtech startup should address its regulatory, intellectual property, and reimbursement strategies from the beginning in lock step with its investment plan and exit strategy.

    Show commercial potential: Strong initial sales or adoption in hospitals and clinics demonstrates the commercial potential of a new medical technology.

    Medical technology research and development is fraught with challenges, including cost, time, and regulatory hurdles. As many entrepreneurs have learned, starting and growing a medtech company is a time-consuming and difficult process, but with careful planning that includes a strategic patent portfolio, innovators can thrive in the market. Seed stage funding, non-dilutive grants, and investment from strategics can help medtech companies cross the funding “valley of death” until the right time for VC investment. 

    References
    1. http://bit.ly/mpo190750 [PDF]
    2. http://bit.ly/mpo190751
    3. http://bit.ly/mpo190752
    4. http://bit.ly/mpo190753
    5. http://bit.ly/mpo190754
    6. http://bit.ly/mpo190755
    7. http://bit.ly/mpo190756


    David J. Dykeman, a registered patent attorney with over 20 years of experience in patent and intellectual property law, is co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group. He can be reached at dykemand@gtlaw.com or at (617) 310-6009.
    Related Searches
    • design
    • cardiovascular
    • technology
    • imaging
    Suggested For You
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    2. Johnson & Johnson 2. Johnson & Johnson
    Verb Surgical Appoints New CEO Verb Surgical Appoints New CEO
    Hologic Partners with MagView to Develop Unifi EQUIP Solution Hologic Partners with MagView to Develop Unifi EQUIP Solution
    Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls
    CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma
    Beyond 510(k)/PMA: De Novo 101—Mike on Medtech Beyond 510(k)/PMA: De Novo 101—Mike on Medtech
    FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps
    Eon FR Receives FDA Clearance Eon FR Receives FDA Clearance
    FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting
    Cook Recalls PTA Balloon Catheters Due to Balloons Bursting Cook Recalls PTA Balloon Catheters Due to Balloons Bursting
    The NYT Editorial Board Statement—Mike on Medtech The NYT Editorial Board Statement—Mike on Medtech
    BRAINBox BRAINBox's Traumatic Brain Injury Test Wins Breakthrough Status
    J&J J&J's Ethicon Acquires Takeda's TachoSil Surgical Patch for $400M
    Massachusetts Medical Device Development Center Names $200K Challenge Winners Massachusetts Medical Device Development Center Names $200K Challenge Winners

    Related Top30

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • Surgical
      Verb Surgical Appoints New CEO

      Verb Surgical Appoints New CEO

      Kurt Azarbarzin most recently served as chief technology officer of ConMed.
      PR Newswire 07.25.19


    • Diagnostics
      Hologic Partners with MagView to Develop Unifi EQUIP Solution

      Hologic Partners with MagView to Develop Unifi EQUIP Solution

      The automated solution will facilitate compliance with FDA guidance.
      Hologic 07.18.19

    • Digital Health | Software & IT
      Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls

      Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls

      SoomSafety is the first mobile app to close the information gap between the U.S. FDA, manufacturers, and medical device users.
      PR Newswire 07.15.19

    Loading, Please Wait..

    Trending
    • Cardinal Health CEO Mike Kaufmann Steps Down
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • TruArc Expands Medical Portfolio With Acquisition Of Molded Devices Inc.
    • Chronic, Infectious Disease Prevalence To Benefit Vital Signs Monitoring Market
    Breaking News
    • BD Recalls Intraosseous Products Over Multiple Issues
    • Rapid Medical Expands U.S. Portfolio
    • MMS Holdings Partners With Lindsay Goldberg
    • ENDRA Life Sciences Issued 28th Patent
    • Levita Magnetics Closes $26M Series C
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    Valspar Reveals Fresh Lineup of New Shades in 2023 Colors of the Year
    Evonik Grows Strongly in 1H 2022
    PPG Chairman and CEO Joins Disability:IN Effort to Advance Disability Inclusion
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BD Recalls Intraosseous Products Over Multiple Issues
    Rapid Medical Expands U.S. Portfolio
    MMS Holdings Partners With Lindsay Goldberg
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Invests $65M to Expand North American HQ
    Pace Appoints Nisheet Gupta as EVP and Chief Financial Officer
    West Pharmaceutical Makes Strategic Investment in Latch Medical
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Murad Unveils Supplement Product Lineup to Combat Acne, Aging
    R+Co Launches New Hairstyling Products
    Clinique Launches Pop Plush Creamy Gloss in its Iconic Black Honey Hue
    Ink World

    Latest Breaking News From Ink World

    Evonik Enjoys 31% Growth in 1H 2022
    Sun Chemical Returns to Labelexpo Americas 2022
    DIC Reports Consolidated Financial Results 1H 2022
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Colordyne hosts open house featuring hybrid print technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business
    Stratasys Signs Agreement to Acquire Covestro’s Additive Manufacturing Materials Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login